Six-Year Rate of Visual Field Progression in the Laser in Glaucoma and Ocular Hypertension Trial

Published

2026

Audience

Therapeutic Area

Content Type

AI Generated Summary*

Post hoc analysis of the LiGHT randomized trial compared visual field mean deviation (MD) decline over six years in 710 patients (one better eye each; 354 randomized to laser first) with newly diagnosed ocular hypertension or open-angle glaucoma. A Bayesian hierarchical mixed model separated true progression from perimetric learning and noise. Estimated MD loss was -0.37 dB/year with drops first and -0.26 dB/year with laser first (P = 0.007), roughly 29% slower. Median follow-up IOP was similar (16.1 versus 16.8 mmHg). By severity, only mild glaucoma reached significance (P = 0.035). Truncating at surgery or switching, and using mean pattern deviation, gave consistent results; worse-eye analysis showed no significant difference.

*This summary was generated by AI and is published unedited. Oku does not alter these summaries. It may contain errors or omissions and is provided for general informational purposes only. Oku does not guarantee its accuracy, completeness, or reliability. For authoritative information, please refer to the original, peer-reviewed article.

At a glance

Authors
Giovanni Montesano; David P. Crabb; David Garway-Heath; David M. Wright; Evgenia Konstantakopoulou; Neil Nathwani; Giovanni Ometto; Gus Gazzard
Publication
Ophthalmology
Keywords
Glaucoma; Ocular Hypertension; Selective Laser Trabeculoplasty; Visual Field Testing; Disease Progression; Intraocular Pressure; Open-Angle Glaucoma; Perimetry
Year
2026
View primary source

This is the evidence

See where we take it next

Join the Network